{
  "schema_version": "3.1.1-production",
  "doc_id": "CT-19846",
  "evaluation_id": "CT-19846",
  "extraction_date": "2022-07-20",
  "extraction_metadata": {
    "processing_version": "auto",
    "extraction_date": "2022-07-20",
    "parser": "auto",
    "annotateur_default": "auto",
    "niveau_confiance_default": 4,
    "source_files": {
      "F1": {
        "file_name": "ct_CT-19846_CIVARON_PIS_INS_Avisdef_CT19865.pdf",
        "type": "CT",
        "page_count": null
      }
    }
  },
  "template_detecte": "CT_modern",
  "section_taxonomy_version": "1.0",
  "SegmentIndex": [
    {
      "segment_id": "CT-19846_seg_01",
      "section_label_normalise": "SYNTHESE_DE_L_AVIS",
      "section_label_brut": "ÉVALUER LES TECHNOLOGIES DE SANTÉ / L’essentiel",
      "template_detecte": "CT_modern",
      "page_start": 1,
      "page_end": 2,
      "char_start": null,
      "char_end": null,
      "heading_text": "ÉVALUER LES TECHNOLOGIES DE SANTÉ AVIS SUR LES MEDICAMENTS Citrate de sodium CIVARON 136mmol/L, Solution pour perfusion / L’essentiel",
      "expected_fields": [
        "avis_favorable",
        "progres",
        "secteur"
      ],
      "routing_hint": "Première page avec résumé",
      "label_confidence": 0.9
    },
    {
      "segment_id": "CT-19846_seg_02",
      "section_label_normalise": "CONTEXTE",
      "section_label_brut": "Contexte",
      "template_detecte": "CT_modern",
      "page_start": 2,
      "page_end": 3,
      "char_start": null,
      "char_end": null,
      "heading_text": "Contexte",
      "expected_fields": [
        "demande_inscription",
        "usage_etabli",
        "anticoagulation",
        "comparateurs_dispositifs"
      ],
      "routing_hint": "Contexte de la demande et informations générales",
      "label_confidence": 0.9
    },
    {
      "segment_id": "CT-19846_seg_03",
      "section_label_normalise": "INDICATIONS_THERAPEUTIQUES",
      "section_label_brut": "Indication",
      "template_detecte": "CT_modern",
      "page_start": 3,
      "page_end": 3,
      "char_start": null,
      "char_end": null,
      "heading_text": "Indication",
      "expected_fields": [
        "indication_AMM"
      ],
      "routing_hint": "Indication selon AMM",
      "label_confidence": 0.9
    },
    {
      "segment_id": "CT-19846_seg_04",
      "section_label_normalise": "COMPARATEURS_PERTINENTS",
      "section_label_brut": "Comparateurs cliniquement pertinents",
      "template_detecte": "CT_modern",
      "page_start": 3,
      "page_end": 4,
      "char_start": null,
      "char_end": null,
      "heading_text": "Comparateurs cliniquement pertinents",
      "expected_fields": [
        "medicaments_comparateurs",
        "dispositifs_comparateurs"
      ],
      "routing_hint": "Liste des comparateurs médicamenteux et non médicamenteux",
      "label_confidence": 0.9
    },
    {
      "segment_id": "CT-19846_seg_05",
      "section_label_normalise": "ETUDES",
      "section_label_brut": "Résumé des données cliniques disponibles",
      "template_detecte": "CT_modern",
      "page_start": 4,
      "page_end": 5,
      "char_start": null,
      "char_end": null,
      "heading_text": "Résumé des données cliniques disponibles",
      "expected_fields": [
        "base_enregistrement",
        "etudes_bibliographiques",
        "efficacite_usage_etabli",
        "tolerance"
      ],
      "routing_hint": "Synthèse des données cliniques (études bibliographiques)",
      "label_confidence": 0.9
    },
    {
      "segment_id": "CT-19846_seg_06",
      "section_label_normalise": "SERVICE_MEDICAL_RENDU",
      "section_label_brut": "Conclusions de la Commission / Service Médical Rendu",
      "template_detecte": "CT_modern",
      "page_start": 6,
      "page_end": 6,
      "char_start": null,
      "char_end": null,
      "heading_text": "Conclusions de la Commission / Service Médical Rendu",
      "expected_fields": [
        "conclusions_smr",
        "gravite_situations",
        "rapport_efficacite_tolerance",
        "alternatives",
        "traitement_premiere_intention"
      ],
      "routing_hint": "Conclusions sur le SMR",
      "label_confidence": 0.9
    },
    {
      "segment_id": "CT-19846_seg_07",
      "section_label_normalise": "AMELIORATION_SMR",
      "section_label_brut": "Amélioration du Service Médical Rendu",
      "template_detecte": "CT_modern",
      "page_start": 6,
      "page_end": 6,
      "char_start": null,
      "char_end": null,
      "heading_text": "Amélioration du Service Médical Rendu",
      "expected_fields": [
        "conclusion_asmr"
      ],
      "routing_hint": "Conclusion sur l'ASMR",
      "label_confidence": 0.9
    },
    {
      "segment_id": "CT-19846_seg_08",
      "section_label_normalise": "POPULATION_CIBLE",
      "section_label_brut": "Population cible",
      "template_detecte": "CT_modern",
      "page_start": 7,
      "page_end": 7,
      "char_start": null,
      "char_end": null,
      "heading_text": "Population cible",
      "expected_fields": [
        "estimation_population_cible"
      ],
      "routing_hint": "Estimation de la population cible",
      "label_confidence": 0.9
    },
    {
      "segment_id": "CT-19846_seg_09",
      "section_label_normalise": "INFORMATIONS_ADMINISTRATIVES",
      "section_label_brut": "Informations administratives et réglementaires",
      "template_detecte": "CT_modern",
      "page_start": 7,
      "page_end": 7,
      "char_start": null,
      "char_end": null,
      "heading_text": "Informations administratives et réglementaires",
      "expected_fields": [
        "date_evaluation",
        "presentations",
        "demandeur",
        "listes",
        "amm",
        "conditions_prescription",
        "code_ATC"
      ],
      "routing_hint": "Informations administratives et réglementaires du produit",
      "label_confidence": 0.9
    },
    {
      "segment_id": "CT-19846_seg_10",
      "section_label_normalise": "ANNEXES",
      "section_label_brut": "Annexes",
      "template_detecte": "CT_modern",
      "page_start": 8,
      "page_end": 11,
      "char_start": null,
      "char_end": null,
      "heading_text": "Annexes",
      "expected_fields": [
        "liste_etudes"
      ],
      "routing_hint": "Liste des études bibliographiques",
      "label_confidence": 0.9
    }
  ],
  "Identifiants_Produits_Liaison": [
    {
      "produit_id": "CT-19846_prod_CIVARON",
      "evaluation_id": "CT-19846",
      "nom_produit": "CIVARON 136mmol/L, Solution pour perfusion",
      "dci": "citrate de sodium",
      "code_cip13": "Non renseigné",
      "code_cis": "Non renseigné",
      "titulaire_amm": "FRESENIUS MEDICAL CARE",
      "comparateur_associe": [],
      "evidence": []
    },
    {
      "produit_id": "CT-19846_prod_REGIOCIT",
      "evaluation_id": "CT-19846",
      "nom_produit": "REGIOCIT",
      "dci": "chlorure de sodium et citrate de sodium",
      "code_cip13": "Non renseigné",
      "code_cis": "Non renseigné",
      "titulaire_amm": "Laboratoire BAXTER SAS",
      "comparateur_associe": [],
      "evidence": []
    },
    {
      "produit_id": "CT-19846_prod_solution_citrate_4pct_DM",
      "evaluation_id": "CT-19846",
      "nom_produit": "Solution de citrate de sodium 4% (dispositif médical)",
      "dci": "citrate de sodium",
      "code_cip13": "Non renseigné",
      "code_cis": "Non renseigné",
      "titulaire_amm": "Fresenius Medical Care",
      "comparateur_associe": [],
      "evidence": []
    },
    {
      "produit_id": "CT-19846_prod_solution_ACD_A",
      "evaluation_id": "CT-19846",
      "nom_produit": "Solution ACD-A",
      "dci": "citrate de sodium",
      "code_cip13": "Non renseigné",
      "code_cis": "Non renseigné",
      "titulaire_amm": "Fresenius KABI AG",
      "comparateur_associe": [],
      "evidence": []
    },
    {
      "produit_id": "CT-19846_prod_citrate_trisodique_4pct",
      "evaluation_id": "CT-19846",
      "nom_produit": "Citrate trisodique 4% w/v",
      "dci": "citrate de sodium",
      "code_cip13": "Non renseigné",
      "code_cis": "Non renseigné",
      "titulaire_amm": "Fresenius Medical Care AG & Co.",
      "comparateur_associe": [],
      "evidence": []
    }
  ],
  "Evaluations_HAS": [
    {
      "evaluation_id": "CT-19846",
      "Num_avis": "CT-19846",
      "produit_nom": "CIVARON 136mmol/L, Solution pour perfusion",
      "dci": "citrate de sodium",
      "type_avis": "Avis favorable au remboursement dans les indications de l’AMM.",
      "type_avis_enum": "Inscription",
      "forme": "Solution pour perfusion",
      "dosage": "136mmol/L",
      "indication": "CIVARON est utilisé pour l’anticoagulation régionale au citrate (ARC) dans le cadre d’une hémodialyse veino-veineuse continue (CVVHD), d’une hémodiafiltration veino-veineuse continue (CVVHDF), d’une dialyse (quotidienne) prolongée à efficacité réduite (SLEDD) et d’un échange plasmatique thérapeutique (EPT) via la séparation de la membrane plasmique. CIVARON est indiqué chez l’adulte et chez l’enfant de tout âge (à l’exception du prématuré).",
      "classe_ATC": "B05ZB",
      "pathologie": "Anticoagulation régionale au citrate pour procédures d'épuration sanguine extracorporelle",
      "maladie_rare": false,
      "ligne_traitement": "Non renseigné",
      "ligne_traitement_enum": null,
      "sous_groupe_population": "Adultes et enfants (sauf prématuré)",
      "cim10_principal": "Non renseigné",
      "cim10_secondaires": [],
      "libelle_cim10": "Non renseigné",
      "source_cim10": "Non renseigné",
      "aire_therapeutique_niveau_1": "Sang et organes hématopoïétiques",
      "aire_therapeutique_niveau_2": "Anticoagulants",
      "aire_therapeutique_niveau_3": "Anticoagulation régionale au citrate",
      "source_aire_therapeutique": "Déduit ATC B05ZB et indication",
      "design_etude": "Usage médical bien établi basé sur données bibliographiques",
      "niveau_preuve_brut": "Usage médical bien établi",
      "niveau_preuve_interprete": "Observationnel_large",
      "besoin_medical_brut": "Non renseigné",
      "besoin_medical_interprete": null,
      "pathologie_categorie_enum": "Autre",
      "age_restriction_flag": true,
      "age_restriction_detail": "Enfant de tout âge sauf prématuré",
      "biomarqueur_requis": "Aucun",
      "design_enum": "Observationnel_prospectif",
      "caractere_innovant_reconnu": false,
      "perte_de_chance_citee": false,
      "historique_Has_produit": "Non renseigné",
      "historique_ASMR_comparateurs": "REGIOCIT : ASMR V par rapport au dispositif médical PRISMOCITRATE 18/0 (avis du 16 mars 2016)",
      "concurrence_therapeutique_recente": "Non renseigné",
      "vote_unanimite": null,
      "nb_votants": null,
      "nb_voix_pour": null,
      "nb_voix_contre": null,
      "nb_abstentions": null,
      "date_evaluation": "2022-07-20",
      "transcription_textuelle": "Non renseigné",
      "extraits_arguments": [],
      "gravite_patho": "Les situations cliniques nécessitant une hémodialyse veino-veineuse continue (CVVHD), une hémodiafiltration veino-veineuse continue (CVVHDF), une dialyse prolongée à efficacité réduite (SLEDD) et un échange plasmatique thérapeutique (EPT) via la séparation de la membrane plasmique sont graves et susceptibles d’engager le pronostic vital des patients.",
      "gravite_patho_enum": [
        "Grave"
      ],
      "type_population_cible": "Adultes et enfants de tout âge (sauf prématuré) nécessitant une anticoagulation régionale au citrate pour CVVHD, CVVHDF, SLEDD ou EPT.",
      "pertinence_concurrence_therapeutique": "Comparateurs cliniquement pertinents : REGIOCIT (chlorure de sodium et citrate de sodium), solution ACD-A, solution citrate trisodique 4%.",
      "evidence": [
        {
          "field": "type_avis",
          "f": "F1",
          "p": 1,
          "s": "L’essen",
          "t": "Avis favorable au remboursement dans les indications de l’AMM.",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "indication",
          "f": "F1",
          "p": 3,
          "s": "Indicat",
          "t": "CIVARON est utilisé pour l’anticoagulation régionale au citrate (ARC) dans le cadre d’une hémodialyse veino-veineuse continue (CVVHD)...",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "classe_ATC",
          "f": "F1",
          "p": 7,
          "s": "Code ATC",
          "t": "B05ZB Solutions pour hémofiltration",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "date_evaluation",
          "f": "F1",
          "p": 1,
          "s": "Adopté p",
          "t": "Adopté par la Commission de la transparence le 20 juillet 2022",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "gravite_patho",
          "f": "F1",
          "p": 6,
          "s": "Les situ",
          "t": "Les situations cliniques nécessitant une hémodialyse veino-veineuse continue (CVVHD)... sont graves et susceptibles d’engager le pronostic vital des patients.",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    }
  ],
  "Essais_Cliniques": [
    {
      "essai_id": "CT-19846_essai_Mehta_1990",
      "evaluation_id": "CT-19846",
      "essai_nom": "Mehta et al., 1990",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Patients en CAVDH (continuous arteriovenous haemodialysis)",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 11,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "11",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Mehta e",
          "t": "Mehta et al., 1990",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "Mehta e",
          "t": "CAVDH (n=11)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Mehta_1991",
      "evaluation_id": "CT-19846",
      "essai_nom": "Mehta et al., 1991",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Patients en CAVDH",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 23,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "23",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Mehta e",
          "t": "Mehta et al., 1991",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CAVDH (",
          "t": "CAVDH (n=23)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Gabutti_2002",
      "evaluation_id": "CT-19846",
      "essai_nom": "Gabutti et al., 2002",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Patients en CVVHDF",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 12,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "12",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Gabutti",
          "t": "Gabutti et al., 2002",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CVVHDF",
          "t": "CVVHDF (n=12)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Tobe_2003",
      "evaluation_id": "CT-19846",
      "essai_nom": "Tobe et al., 2003",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Patients en CVVHDF",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 30,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "30",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Tobe et",
          "t": "Tobe et al., 2003",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CVVHDF",
          "t": "CVVHDF (n=30)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Monchi_2004",
      "evaluation_id": "CT-19846",
      "essai_nom": "Monchi et al., 2004",
      "nct_number": "Non renseigné",
      "design": "RCT",
      "design_enum": "Phase_III_RCT_ouvert",
      "population_cible": "Patients en CVVHDF",
      "comparateur_utilise": "héparine",
      "nb_patient_traitement": 26,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Ouvert",
      "randomisation_flag": true,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": "Traitement_actif",
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "26",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Monchi e",
          "t": "Monchi et al., 2004",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CVVHDF",
          "t": "CVVHDF (n=26)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Morgera_2004",
      "evaluation_id": "CT-19846",
      "essai_nom": "Morgera et al., 2004",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Patients en CVVHD",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 37,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "37",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Morgera",
          "t": "Morgera et al., 2004",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CVVHD (",
          "t": "CVVHD (n=37)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Morgera_2005",
      "evaluation_id": "CT-19846",
      "essai_nom": "Morgera et al., 2005",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Patients en CVVHD",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 23,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "23",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Morgera",
          "t": "Morgera et al., 2005",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CVVHD (",
          "t": "CVVHD (n=23)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Morgera_2009",
      "evaluation_id": "CT-19846",
      "essai_nom": "Morgera et al., 2009",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Patients en CVVHD",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 162,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "162",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Morgera",
          "t": "Morgera et al., 2009",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CVVHD (",
          "t": "CVVHD (n=162)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Raimundo_2013",
      "evaluation_id": "CT-19846",
      "essai_nom": "Raimundo et al., 2013",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Patients en CVVHD",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 30,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "30",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Raimundo",
          "t": "Raimundo et al., 2013",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CVVHD (",
          "t": "CVVHD (n=30)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Slowinski_2015",
      "evaluation_id": "CT-19846",
      "essai_nom": "Slowinski et al., 2015",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Patients en CVVHD avec insuffisance hépatique",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 133,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "133",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Slowinsk",
          "t": "Slowinski et al., 2015",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CVVHD (",
          "t": "CVVHD (n=133)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Tolwani_2001",
      "evaluation_id": "CT-19846",
      "essai_nom": "Tolwani et al., 2001",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Patients en CVVHD",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 23,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "23",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Tolwani ",
          "t": "Tolwani et al., 2001",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CVVHD (",
          "t": "CVVHD (n=23)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Schilder_2014",
      "evaluation_id": "CT-19846",
      "essai_nom": "Schilder et al., 2014",
      "nct_number": "Non renseigné",
      "design": "RCT",
      "design_enum": "Phase_III_RCT_ouvert",
      "population_cible": "Patients en CVVHF",
      "comparateur_utilise": "héparine",
      "nb_patient_traitement": 66,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Ouvert",
      "randomisation_flag": true,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": "Traitement_actif",
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "66",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 8,
          "s": "Schilder ",
          "t": "Schilder et al., 2014",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 8,
          "s": "CVVHF (",
          "t": "CVVHF (n=66)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Chadha_2002",
      "evaluation_id": "CT-19846",
      "essai_nom": "Chadha et al., 2002",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Enfants en CVVH",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 5,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": 1.5,
      "age_max_num": 11,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "5",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 9,
          "s": "Chadha e",
          "t": "Chadha et al., 2002",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 9,
          "s": "CVVH (n",
          "t": "CVVH (n=5)",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "age_min_num",
          "f": "F1",
          "p": 9,
          "s": "Enfants ",
          "t": "Enfants 1,5 à 11 ans",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Raymakers-janssen_2017",
      "evaluation_id": "CT-19846",
      "essai_nom": "Raymakers-janssen et al., 2017",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Enfants de poids <15 kg en EERC",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 14,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "14",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 9,
          "s": "Raymaker",
          "t": "Raymakers-janssen et al., 2017",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 9,
          "s": "EERC (n=",
          "t": "EERC (n=14)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Musielak_2016",
      "evaluation_id": "CT-19846",
      "essai_nom": "Musielak et al., 2016",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Nouveaux-nés et <3 ans en CVVHDF",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 15,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": 3,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "15",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 9,
          "s": "Musielak",
          "t": "Musielak et al., 2016",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 9,
          "s": "CVVHDF ",
          "t": "CVVHDF (n=15)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Liet_2014",
      "evaluation_id": "CT-19846",
      "essai_nom": "Liet et al., 2014",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Enfants en CVVH",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 10,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": 3,
      "age_max_num": 15,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "10",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 9,
          "s": "Liet et ",
          "t": "Liet et al., 2014",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 9,
          "s": "CVVH (n",
          "t": "CVVH (n=10)",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "age_min_num",
          "f": "F1",
          "p": 9,
          "s": "Age : 3",
          "t": "Age : 3 à 15 ans",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Soltysiak_2014",
      "evaluation_id": "CT-19846",
      "essai_nom": "Soltysiak et al., 2014",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Enfants en CVVHF",
      "comparateur_utilise": "héparine",
      "nb_patient_traitement": 16,
      "nb_patient_comparateur": 14,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": "Traitement_actif",
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "16",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 9,
          "s": "Soltysia",
          "t": "Soltysiak et al., 2014",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 9,
          "s": "CVVHF (n",
          "t": "CVVHF (n=16)",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_comparateur",
          "f": "F1",
          "p": 9,
          "s": "Héparine",
          "t": "Héparine - CVVHF (n=14)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "essai_id": "CT-19846_essai_Rodriguez_2017",
      "evaluation_id": "CT-19846",
      "essai_nom": "Rodriguez et al., 2017",
      "nct_number": "Non renseigné",
      "design": "Observationnel",
      "design_enum": "Observationnel_prospectif",
      "population_cible": "Enfants en CVVHDF avec insuffisance hépatique",
      "comparateur_utilise": "Non renseigné",
      "nb_patient_traitement": 51,
      "nb_patient_comparateur": null,
      "resultat_global": "Non renseigné",
      "QoL_flag": false,
      "niveau_preuve": "Non renseigné",
      "pooling_flag": false,
      "population_dedoublée": false,
      "suivi_median_mois": null,
      "arret_premature_flag": false,
      "duree_traitement_moyenne_mois": null,
      "phase": "Non renseigné",
      "aveugle": "Non_applicable",
      "randomisation_flag": false,
      "randomisation_ratio": "Non renseigné",
      "stratification_flag": false,
      "stratification_facteurs": [],
      "population_analyse_principale": "Non renseigné",
      "date_cutoff_donnees": "Non renseigné",
      "duree_suivi_prevu_mois": null,
      "maturite_donnees": "Non renseigné",
      "age_min_num": null,
      "age_max_num": null,
      "ligne_traitement_essai_enum": "Non renseigné",
      "comparateur_type_enum": null,
      "efficacite_demontree": null,
      "magnitude_effet_categorie": "Non renseigné",
      "maturite_pct": null,
      "arret_premature_raison": "Non applicable",
      "arret_premature_date": "Non renseigné",
      "analyse_interimaire_plannifiee": false,
      "qol_instruments": [],
      "qol_resultats_brut": "Non renseigné",
      "qol_difference_cliniquement_pertinente": null,
      "qol_favorable": null,
      "nb_facteurs_stratification": null,
      "nb_patients_inclus": "51",
      "nb_patients_inclus_par_pays": [],
      "date_fin_inclusion": "Non renseigné",
      "nb_analyses_intermediaire": null,
      "date_analyses_intermediares_mois": [],
      "evidence": [
        {
          "field": "essai_nom",
          "f": "F1",
          "p": 9,
          "s": "Rodrigue",
          "t": "Rodriguez et al., 2017",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "nb_patient_traitement",
          "f": "F1",
          "p": 9,
          "s": "CVVHDF ",
          "t": "CVVHDF (n=51)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    }
  ],
  "Critères_Jugement": [],
  "Tolérance": [
    {
      "tolerance_id": "CT-19846_tol",
      "evaluation_id": "CT-19846",
      "essai_id": null,
      "ae_total_pct": null,
      "ae_total_pct_comparateur": null,
      "sae_pct": null,
      "sae_pct_comparateur": null,
      "discontinuations_ae_pct": null,
      "discontinuations_ae_pct_comparateur": null,
      "deaths_ae_n": null,
      "deaths_ae_n_comparateur": null,
      "sae_data_available": false,
      "sae_superieur_comparateur": null,
      "deaths_reported": false,
      "EI_graves_detailles": [],
      "EI_frequents_detailles": [
        {
          "ei_terme": "hypocalcémie",
          "grade": "Tous grades",
          "incidence_pct_traitement": null,
          "incidence_pct_comparateur": null,
          "evidence": []
        },
        {
          "ei_terme": "hypernatrémie",
          "grade": "Tous grades",
          "incidence_pct_traitement": null,
          "incidence_pct_comparateur": null,
          "evidence": []
        },
        {
          "ei_terme": "alcalose métabolique",
          "grade": "Tous grades",
          "incidence_pct_traitement": null,
          "incidence_pct_comparateur": null,
          "evidence": []
        }
      ],
      "ei_grade_max": "Non renseigné",
      "deces_detailles": [],
      "signal_securite_flag": false,
      "signal_securite_detailles": [],
      "signal_ansm_flag": false,
      "EI_graves": "Non renseigné",
      "EI_frequents": "Effets indésirables très fréquents (≥ 1/10) attendus : hypocalcémie (< 1,1 mmol/L), hypernatrémie (> 145 mmol/L) et alcalose métabolique (pH > 7,45).",
      "deces": "Non renseigné",
      "signal_securite": "Non renseigné",
      "evidence": [
        {
          "field": "EI_frequents",
          "f": "F1",
          "p": 5,
          "s": "Concerna",
          "t": "Effets indésirables très fréquents (≥ 1/10) attendus avec l’utilisation de CIVARON... : l’hypocalcémie, l’hypernatrémie et l’alcalose métabolique.",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    }
  ],
  "Comparateurs_Essai": [
    {
      "comparateur_id": "CT-19846_essai_Monchi_2004_comp_01",
      "essai_id": "CT-19846_essai_Monchi_2004",
      "nom_comparateur": "héparine",
      "type_comparateur": "ActiveComparator",
      "comparateur_standard_soin": "Non renseigné",
      "comparateur_standard_enum": "Autre",
      "evidence": [
        {
          "field": "nom_comparateur",
          "f": "F1",
          "p": 8,
          "s": "Monchi e",
          "t": "Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "comparateur_id": "CT-19846_essai_Schilder_2014_comp_01",
      "essai_id": "CT-19846_essai_Schilder_2014",
      "nom_comparateur": "héparine",
      "type_comparateur": "ActiveComparator",
      "comparateur_standard_soin": "Non renseigné",
      "comparateur_standard_enum": "Autre",
      "evidence": [
        {
          "field": "nom_comparateur",
          "f": "F1",
          "p": 8,
          "s": "Schilder ",
          "t": "Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "comparateur_id": "CT-19846_essai_Soltysiak_2014_comp_01",
      "essai_id": "CT-19846_essai_Soltysiak_2014",
      "nom_comparateur": "héparine",
      "type_comparateur": "ActiveComparator",
      "comparateur_standard_soin": "Non renseigné",
      "comparateur_standard_enum": "Autre",
      "evidence": [
        {
          "field": "nom_comparateur",
          "f": "F1",
          "p": 9,
          "s": "Soltysia",
          "t": "Héparine - CVVHF (n=14)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    }
  ],
  "Comparateurs_HAS": [
    {
      "comparateur_id": "CT-19846_compHAS_01",
      "evaluation_id": "CT-19846",
      "nom_comparateur_HAS": "REGIOCIT (chlorure de sodium et citrate de sodium), solution pour hémofiltration",
      "type_comparateur": "Médicament",
      "comparateur_standard_soin": "Solution de substitution pour la thérapie d’épuration extra-rénale continue (EERC) utilisant l’anticoagulation régionale au citrate.",
      "famille_comparateur": "Autre",
      "evidence": [
        {
          "field": "nom_comparateur_HAS",
          "f": "F1",
          "p": 3,
          "s": "Médicam",
          "t": "REGIOCIT (chlorure de sodium et citrate de sodium), solution pour hémofiltration",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "comparateur_id": "CT-19846_compHAS_02",
      "evaluation_id": "CT-19846",
      "nom_comparateur_HAS": "Solution ACD-A",
      "type_comparateur": "Dispositif médical",
      "comparateur_standard_soin": "Solution de citrate de sodium pour anticoagulation",
      "famille_comparateur": "Autre",
      "evidence": [
        {
          "field": "nom_comparateur_HAS",
          "f": "F1",
          "p": 4,
          "s": "Comparat",
          "t": "Solution ACD-A (Fabricant: Fresenius KABI AG, classe IIb, CE0123)",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "comparateur_id": "CT-19846_compHAS_03",
      "evaluation_id": "CT-19846",
      "nom_comparateur_HAS": "Citrate trisodique 4% w/v Solution pour traitement sanguin extracorporel",
      "type_comparateur": "Dispositif médical",
      "comparateur_standard_soin": "Destinée à l’anticoagulation régionale dans le cadre de l’épuration extra-rénale continue (EERC) chez l’adulte.",
      "famille_comparateur": "Autre",
      "evidence": [
        {
          "field": "nom_comparateur_HAS",
          "f": "F1",
          "p": 4,
          "s": "Citrate ",
          "t": "Citrate trisodique 4% w/v Solution pour traitement sanguin extracorporel",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    }
  ],
  "Arguments_Decisionnels": [
    {
      "argument_id": "CT-19846_arg_CT_1",
      "evaluation_id": "CT-19846",
      "source_argument": "CT",
      "categorie_argument": "Efficacité",
      "description": "Efficacité évaluée sur la base d'un usage médical bien établi dans les indications, avec des données bibliographiques étayant l'usage du citrate de sodium pour l'anticoagulation régionale.",
      "direction_argument": "Favorable",
      "importance_argument": "Majeur",
      "niveau_incertitude": "Faible",
      "extrait_textuel": "L'efficacité de CIVARON est évaluée sur la base d’un usage bien établi dans ces indications.",
      "page_source": "Page 5",
      "section_source": "Résumé des données cliniques disponibles",
      "intervenant": null,
      "moment_debat": null,
      "impact_decision": "Contributeur_majeur",
      "evidence": [
        {
          "field": "description",
          "f": "F1",
          "p": 5,
          "s": "L’effica",
          "t": "L'efficacité de CIVARON est évaluée sur la base d’un usage bien établi dans ces indications.",
          "m": "rule",
          "c": 1.0
        }
      ]
    },
    {
      "argument_id": "CT-19846_arg_CT_2",
      "evaluation_id": "CT-19846",
      "source_argument": "CT",
      "categorie_argument": "Tolérance",
      "description": "Profil de tolérance acceptable avec effets indésirables très fréquents attendus (hypocalcémie, hypernatrémie, alcalose métabolique) mais gérables.",
      "direction_argument": "Neutre",
      "importance_argument": "Important",
      "niveau_incertitude": "Faible",
      "extrait_textuel": "Les effets indésirables très fréquents (≥ 1/10) attendus avec l’utilisation de CIVARON... sont : l’hypocalcémie, l’hypernatrémie et l’alcalose métabolique.",
      "page_source": "Page 5",
      "section_source": "Résumé des données cliniques disponibles",
      "intervenant": null,
      "moment_debat": null,
      "impact_decision": "Contributeur",
      "evidence": [
        {
          "field": "extrait_textuel",
          "f": "F1",
          "p": 5,
          "s": "Les effe",
          "t": "Les effets indésirables très fréquents (≥ 1/10) attendus avec l’utilisation de CIVARON... sont : l’hypocalcémie, l’hypernatrémie et l’alcalose métabolique.",
          "m": "rule",
          "c": 1.0
        }
      ]
    },
    {
      "argument_id": "CT-19846_arg_CT_3",
      "evaluation_id": "CT-19846",
      "source_argument": "CT",
      "categorie_argument": "Besoin_médical",
      "description": "Situations cliniques nécessitant une anticoagulation régionale au citrate (CVVHD, CVVHDF, SLEDD, EPT) sont graves et susceptibles d'engager le pronostic vital.",
      "direction_argument": "Favorable",
      "importance_argument": "Majeur",
      "niveau_incertitude": "Faible",
      "extrait_textuel": "Les situations cliniques nécessitant une hémodialyse veino-veineuse continue (CVVHD)... sont graves et susceptibles d’engager le pronostic vital des patients.",
      "page_source": "Page 6",
      "section_source": "Service Médical Rendu",
      "intervenant": null,
      "moment_debat": null,
      "impact_decision": "Contributeur_majeur",
      "evidence": [
        {
          "field": "extrait_textuel",
          "f": "F1",
          "p": 6,
          "s": "Les situ",
          "t": "Les situations cliniques nécessitant une hémodialyse veino-veineuse continue (CVVHD)... sont graves et susceptibles d’engager le pronostic vital des patients.",
          "m": "rule",
          "c": 1.0
        }
      ]
    },
    {
      "argument_id": "CT-19846_arg_CT_4",
      "evaluation_id": "CT-19846",
      "source_argument": "CT",
      "categorie_argument": "Comparaison",
      "description": "Pas de progrès par rapport au dispositif médical solution de citrate de sodium 4% et par rapport à la spécialité REGIOCIT ; ASMR V.",
      "direction_argument": "Neutre",
      "importance_argument": "Important",
      "niveau_incertitude": "Faible",
      "extrait_textuel": "Pas de progrès par rapport au dispositif médical solution de citrate de sodium 4% et par rapport à la spécialité REGIOCIT.",
      "page_source": "Page 1",
      "section_source": "L’essentiel",
      "intervenant": null,
      "moment_debat": null,
      "impact_decision": "Contributeur",
      "evidence": [
        {
          "field": "extrait_textuel",
          "f": "F1",
          "p": 1,
          "s": "Quel pro",
          "t": "Pas de progrès par rapport au dispositif médical solution de citrate de sodium 4% et par rapport à la spécialité REGIOCIT.",
          "m": "rule",
          "c": 1.0
        }
      ]
    },
    {
      "argument_id": "CT-19846_arg_CT_5",
      "evaluation_id": "CT-19846",
      "source_argument": "CT",
      "categorie_argument": "Place_thérapeutique",
      "description": "Traitement de première intention pour l'anticoagulation régionale au citrate dans les indications.",
      "direction_argument": "Favorable",
      "importance_argument": "Modéré",
      "niveau_incertitude": "Faible",
      "extrait_textuel": "Il s’agit d’un traitement de première intention.",
      "page_source": "Page 6",
      "section_source": "Service Médical Rendu",
      "intervenant": null,
      "moment_debat": null,
      "impact_decision": "Contributeur",
      "evidence": [
        {
          "field": "extrait_textuel",
          "f": "F1",
          "p": 6,
          "s": "Il s’agi",
          "t": "Il s’agit d’un traitement de première intention.",
          "m": "rule",
          "c": 1.0
        }
      ]
    },
    {
      "argument_id": "CT-19846_arg_CT_6",
      "evaluation_id": "CT-19846",
      "source_argument": "CT",
      "categorie_argument": "Économique",
      "description": "Pas d'impact supplémentaire sur la santé publique malgré la gravité des situations, en raison de la prévalence difficile à estimer et de l'impact positif non démontré sur l'organisation des soins.",
      "direction_argument": "Neutre",
      "importance_argument": "Modéré",
      "niveau_incertitude": "Modérée",
      "extrait_textuel": "CIVARON 136mmol/L, solution pour perfusion n’est pas susceptible d’avoir un impact supplémentaire sur la santé publique.",
      "page_source": "Page 6",
      "section_source": "Intérêt de santé publique",
      "intervenant": null,
      "moment_debat": null,
      "impact_decision": "Contributeur",
      "evidence": [
        {
          "field": "extrait_textuel",
          "f": "F1",
          "p": 6,
          "s": "CIVARON ",
          "t": "CIVARON 136mmol/L, solution pour perfusion n’est pas susceptible d’avoir un impact supplémentaire sur la santé publique.",
          "m": "rule",
          "c": 1.0
        }
      ]
    }
  ],
  "Données_Contexte": {
    "contexte_id": "CT-19846_ctx",
    "evaluation_id": "CT-19846",
    "ISP": "Non renseigné",
    "acces_precoce": "Aucun",
    "date_debut_acces_precoce": "Non renseigné",
    "date_fin_acces_precoce": "Non renseigné",
    "duree_acces_precoce_mois": null,
    "nombre_patients_acces_precoce": null,
    "conditions_arret_acces_precoce": "Non renseigné",
    "ISP_flag": false,
    "ISP_categorie": "Pas_ISP",
    "type_acces_precoce_enum": "Aucun",
    "statut_reglementaire_ema": "AMM_standard",
    "date_AMM_ema": "2021-12-09",
    "date_avis_chmp": "Non renseigné",
    "innovation_therapeutique_ema": false,
    "designation_orpheline_ema": false,
    "prime_ema": false,
    "obligations_post_amm": [],
    "echeance_reexamen_amm": "Non renseigné",
    "nb_obligations_post_amm": null,
    "evaluation_internationale": "Oui",
    "pays_evaluations": [
      "Union Européenne"
    ],
    "decisions_internationales": [
      {
        "pays": "Union Européenne",
        "organisme": "EMA",
        "decision": "Recommended",
        "date_decision": "2021-10-27",
        "reference": "AMM européenne octroyée le 27/10/2021",
        "evidence": []
      }
    ],
    "nb_decisions_internationales": 1,
    "RDCR": "Non renseigné",
    "RDCR_num": null,
    "RDCR_intervalle": null,
    "RDCR_vs_seuil": "Non_applicable",
    "model_type": "Non renseigné",
    "perspective": "Non renseigné",
    "horizon_annees": null,
    "horizon_justification": "Non renseigné",
    "discount_rate_costs": null,
    "discount_rate_qalys": null,
    "DSA_flag": null,
    "PSA_flag": null,
    "scenario_analyses": [],
    "major_reserves": [],
    "nb_reserves_majeures": null,
    "impact_budgetaire_prevu": "Non renseigné",
    "impact_budgetaire_annee_1": null,
    "impact_budgetaire_annee_5": null,
    "impact_budgetaire_horizon": null,
    "hypothese_population_cible": 11500,
    "hypothese_penetration_marche_pct": null,
    "reserves_impact_budgetaire": [],
    "reserves_majeures": false,
    "population_cible_france": "Patients traités par EERC sous anticoagulation au citrate",
    "population_cible_nombre": 11500,
    "population_cible_intervalle": null,
    "source_estimation_population": "Données labo",
    "incertitude_population": "Élevée",
    "population_cible_mediane": 11500,
    "suivi_post_inscription": false,
    "nature_suivi_post_inscription": "Non_applicable",
    "delai_suivi_mois": null,
    "delai_suivi_justification": "Non renseigné",
    "conditions_suivi": "Non renseigné",
    "echeance_suivi": "Non renseigné",
    "impact_si_non_realise": "Non précisé",
    "delai_soumission_dossier": "Non renseigné",
    "delai_complement_demande": null,
    "dates_complement_demande": [],
    "delai_audition": null,
    "date_audition": "Non renseigné",
    "nb_total_reserves": null,
    "nb_total_reserves_mineures": null,
    "nb_totales_reserves_importantes": null,
    "nb_totales_reserves_majeures": null,
    "SMR_avant_audition_enum": "Non_renseigné",
    "SMR_apres_audition_enum": "Non_renseigné",
    "ASMR_avant_audition_enum": "Non_renseigné",
    "ASMR_après_audition_enum": "Non_renseigné",
    "type_critère_justification": "Non renseigné",
    "valeur_critère": "Non renseigné",
    "impact_décision": "Non renseigné",
    "estimation_mesure_impact": "Non renseigné",
    "evidence": [
      {
        "field": "date_AMM_ema",
        "f": "F1",
        "p": 7,
        "s": "AMM",
        "t": "Date initiale (procédure décentralisée) : 09/12/2021",
        "m": "rule",
        "c": 1.0
      },
      {
        "field": "decisions_internationales",
        "f": "F1",
        "p": 4,
        "s": "A ce jou",
        "t": "AMM dans 26 pays de l’Union Européenne... AMM européenne ayant été octroyée le 27/10/2021",
        "m": "rule",
        "c": 1.0
      },
      {
        "field": "hypothese_population_cible",
        "f": "F1",
        "p": 7,
        "s": "Compte t",
        "t": "Le nombre de patients traités par EERC sous anticoagulation au citrate a été estimé à 11 500 patients par an en France.",
        "m": "rule",
        "c": 1.0
      }
    ],
    "_meta": {}
  },
  "Données_Textuelles": {
    "evaluation_id": "CT-19846",
    "texte_brut": "Non renseigné",
    "embedding": null,
    "evidence": []
  },
  "SMR_ASMR_Par_Indication": [
    {
      "smr_asmr_id": "CT-19846_smrasmr_01",
      "evaluation_id": "CT-19846",
      "indication_precise": "Anticoagulation régionale au citrate (ARC) dans le cadre d'une CVVHD, CVVHDF, SLEDD, EPT chez l'adulte et l'enfant (sauf prématuré).",
      "smr": "La Commission considère que le service médical rendu par CIVARON 136mmol/L (citrate de sodium) est important dans l’indication de l’AMM.",
      "asmr": "La Commission considère que CIVARON n’apporte pas d’amélioration du service médical rendu (ASMR V) dans la stratégie thérapeutique par rapport à la solution de citrate de sodium 4% classée comme dispositif médical et par rapport à la spécialité REGIOCIT.",
      "smr_revendique": "Non renseigné",
      "asmr_revendique": "Non renseigné",
      "asmr_revendique_enum": "Non_renseigné",
      "justification_decisionnelle": "Situations cliniques graves, rapport efficacité/effets indésirables important, existence d'alternatives, traitement de première intention.",
      "population_cible_indication": "Adultes et enfants de tout âge (sauf prématuré) nécessitant une anticoagulation régionale au citrate pour CVVHD, CVVHDF, SLEDD ou EPT.",
      "ligne_traitement_indication": "Première intention",
      "comparateurs_references_indication": [
        "REGIOCIT",
        "Solution de citrate de sodium 4% (dispositif médical)"
      ],
      "comparateur_id_HAS": [
        "CT-19846_compHAS_01",
        "CT-19846_prod_solution_citrate_4pct_DM"
      ],
      "indication_structuree": {
        "ligne_traitement": "1L",
        "biomarqueur": "Aucun",
        "stade": "Non renseigné",
        "population_age": "Adultes et enfants (sauf prématuré)"
      },
      "gain_survie_cite": false,
      "qol_cite": false,
      "tolerance_acceptable": true,
      "evidence_robustesse": "Modérée",
      "evidence": [
        {
          "field": "smr",
          "f": "F1",
          "p": 6,
          "s": "La Comm",
          "t": "La Commission considère que le service médical rendu par CIVARON 136mmol/L (citrate de sodium) est important dans l’indication de l’AMM.",
          "m": "rule",
          "c": 1.0
        },
        {
          "field": "asmr",
          "f": "F1",
          "p": 6,
          "s": "La Comm",
          "t": "La Commission considère que CIVARON n’apporte pas d’amélioration du service médical rendu (ASMR V)...",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    }
  ],
  "Posologie_Par_Indication": [],
  "Timeline_Evenements": [
    {
      "event_id": "CT-19846_event_AMM_01",
      "evaluation_id": "CT-19846",
      "event_type": "AMM_EMA_DECISION",
      "event_date": "2021-12-09",
      "detail_brut": "Date initiale d'AMM (procédure décentralisée)",
      "source_doc": "F1",
      "detail_type_specifique": "AMM européenne",
      "acteurs_impliques": [
        "EMA",
        "FRESENIUS MEDICAL CARE"
      ],
      "duree_evenement_jours": null,
      "reference_externe": "DCP DE/H/6388/001/DC",
      "evidence": [
        {
          "field": "event_date",
          "f": "F1",
          "p": 7,
          "s": "AMM",
          "t": "Date initiale (procédure décentralisée) : 09/12/2021",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    },
    {
      "event_id": "CT-19846_event_CT_01",
      "evaluation_id": "CT-19846",
      "event_type": "ADOPTION_CT",
      "event_date": "2022-07-20",
      "detail_brut": "Adoption de l'avis par la Commission de la transparence",
      "source_doc": "F1",
      "detail_type_specifique": "Avis favorable au remboursement",
      "acteurs_impliques": [
        "Commission de la transparence HAS"
      ],
      "duree_evenement_jours": null,
      "reference_externe": "Non renseigné",
      "evidence": [
        {
          "field": "event_date",
          "f": "F1",
          "p": 1,
          "s": "Adopté p",
          "t": "Adopté par la Commission de la transparence le 20 juillet 2022",
          "m": "rule",
          "c": 1.0
        }
      ],
      "_meta": {}
    }
  ],
  "Timeline_Delais": {
    "evaluation_id": "CT-19846",
    "delai_amm_ct_jours": 223,
    "delai_transcription_ct_jours": null,
    "delai_audition_ct_jours": null,
    "complement_demande_mentionne": false,
    "audition_realisee": false,
    "evidence": [],
    "_meta": {}
  },
  "Features_Modele": {
    "evaluation_id": "CT-19846",
    "is_orphan": false,
    "classe_ATC_l2": "B05",
    "aire_therapeutique": "Sang et organes hématopoïétiques",
    "type_avis_enum": "Inscription",
    "innovation_reconnue": false,
    "perte_de_chance_citee": false,
    "ligne_traitement_num": 1,
    "is_rct": false,
    "n_essais": 18,
    "n_rct": 2,
    "presence_qol": false,
    "effet_principal_magnitude_num": null,
    "critere_principal_dur": false,
    "suivi_median_mois_max": null,
    "sae_pct_num": null,
    "discontinuations_pct_num": null,
    "critere_principal_description": "Non renseigné",
    "p_value_log10": null,
    "ceesp_present": false,
    "rdcr_num": null,
    "rdcr_log": null,
    "impact_budget_cat": "Non renseigné",
    "reserves_majeures": false,
    "nb_reserves_majeures": 0,
    "vote_unanimite": null,
    "nb_votants": null,
    "voix_pour_pct": null,
    "association_patient_intervenue": false,
    "comparateur_placebo": false,
    "comparateur_soc": false,
    "nb_clockstops": 0,
    "annee_ct": 2022,
    "trimestre_ct": 3,
    "template_ere": "CT_modern",
    "missingness_indicators": {},
    "_meta": {}
  },
  "Relations": [
    {
      "src_type": "EVAL_HAS",
      "src_id": "CT-19846",
      "tgt_type": "TRIAL",
      "tgt_id": "CT-19846_essai_Mehta_1990",
      "label": "EVAL_HAS_TRIAL"
    },
    {
      "src_type": "TRIAL",
      "src_id": "CT-19846_essai_Monchi_2004",
      "tgt_type": "COMPARATOR",
      "tgt_id": "CT-19846_essai_Monchi_2004_comp_01",
      "label": "TRIAL_HAS_COMPARATOR"
    },
    {
      "src_type": "EVAL_HAS",
      "src_id": "CT-19846",
      "tgt_type": "COMPARATOR_HAS",
      "tgt_id": "CT-19846_compHAS_01",
      "label": "EVAL_HAS_COMPARATOR"
    }
  ],
  "Annotation_View": []
}